Title : Antitumor T-cell Immunity Contributes to Pancreatic Cancer Immune Resistance.

Pub. Date : 2021 Apr

PMID : 33509790






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Targeting the Janus Kinase (JAK)/STAT signaling pathway using the FDA approved drug ruxolitinib overcame these tumor-protective responses and improved anti-PD-1 therapeutic efficacy. ruxolitinib programmed cell death 1 Mus musculus